Is there a clinically significant interaction between sirolimus and rosuvastatin?

Sirolimus and Rosuvastatin: Clinically Significant Interaction

Yes, there is a clinically significant interaction between sirolimus and rosuvastatin, but the combination may be used with strict dose limitations—rosuvastatin should not exceed 5 mg daily when coadministered with sirolimus.

Key Recommendation

The 2016 American Heart Association Scientific Statement provides explicit guidance on this drug-drug interaction 1. The combination of sirolimus with rosuvastatin may be considered, but daily doses of rosuvastatin must be limited to 5 mg when used with sirolimus 1.

Mechanism and Risk

The interaction occurs through multiple pathways:

• Sirolimus inhibits OATP1B1 (organic anion-transporting polypeptide), a key hepatic uptake transporter for rosuvastatin
• All statins on the US market, including rosuvastatin, are substrates for OATP1B1 1
• This inhibition increases rosuvastatin plasma concentrations, elevating the risk of myopathy and rhabdomyolysis—the primary safety concern that can lead to significant morbidity and mortality

Clinical Context

This interaction is particularly relevant in transplant recipients, where sirolimus is commonly used as an immunosuppressant and statins are cornerstone therapy. The International Society of Heart and Lung Transplantation recommends statins beginning 1-2 weeks after heart transplantation due to their benefits in reducing mortality, rejection, and coronary artery vasculopathy 1.

Practical Management Algorithm

If sirolimus and rosuvastatin must be used together:

1. Limit rosuvastatin to maximum 5 mg daily 1
2. Monitor closely for muscle-related toxicity:
   • Check creatinine kinase (CK) levels regularly
   • Assess for muscle pain, weakness, or tenderness
   • Educate patients to report any muscle symptoms immediately
3. Consider alternative statins if higher doses are needed:
   • Pravastatin (maximum 20 mg daily with sirolimus) 1
   • Fluvastatin (maximum 40 mg daily with sirolimus) 1

Statins to Avoid with Sirolimus

Do not use these statins with sirolimus as they carry potentially harmful risk 1:

• Lovastatin
• Simvastatin
• Pitavastatin

Critical Pitfalls to Avoid

• Do not assume rosuvastatin is "safe" without dose adjustment—while the combination may be considered, the 5 mg daily limit is mandatory
• Do not overlook muscle symptoms—even mild myalgias warrant CK measurement and potential dose reduction or discontinuation
• Do not use higher rosuvastatin doses even if lipid goals are not met; switch to alternative lipid-lowering strategies instead

The evidence consistently demonstrates that while rosuvastatin can be used with sirolimus, strict adherence to the 5 mg daily maximum is essential to minimize the risk of potentially fatal rhabdomyolysis.